The European Prevention of Alzheimer’s Dementia (EPAD) consortium, in their partnership with Aridhia and Alzheimer’s Disease Data Initiative (ADDI), have announced that the EPAD genomic data has been incorporated into the Alzheimer’s Disease (AD) Workbench to provide even greater value to the global neuroscience research community. A key achievement of the EPAD project was the establishment of a Longitudinal Cohort Study (LCS) that has screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data to help further the understanding of the early stages of Alzheimer’s disease.
EPAD has made this database open access and publicly available to the research community through the AD Workbench, which is an open, global and free cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. This incredibly rich data source has now been enriched with the EPAD genomic data. It is an important step in continuing to share the EPAD LCS data in the long-term and ensuring that this valuable resource is used by the research community to generate as much knowledge as possible.
https://ep-ad.org/the-epad-genomic-data-is-now-available-on-the-alzheimers-disease-workbench/
